$ABT and $GOOGL just announced a multi-year partnership merging Abbott's Lingo continuous glucose monitor with Google's AI health coaching platform. Launch expected in 2026.

The deal lets users feed real-time glucose data into Google's Health Coach alongside activity, sleep, and nutrition metrics for personalized metabolic guidance. They're also running a large-scale research study to refine the AI recommendations.

Context: 115 million U.S. adults have prediabetes. CGM tech has mostly been diabetes-focused. This pushes it into the broader wellness market.

Abbott gets distribution through Google's consumer health ecosystem. Google gets biometric data to train its health AI. Both get a foothold in metabolic health before it becomes crowded.

The 2026 timeline suggests this is still early-stage integration. Real question is whether consumers will pay for glucose monitoring when they don't have diabetes, and whether insurers will cover it for prevention. If adoption scales, this could redefine how people think about food and energy management.

Watch how this plays against Apple's rumored non-invasive glucose work and the broader wearables race.